Conference
Dupilumab reduces oral corticosteroid (OCS) use and severe exacerbations, and improves FEV1 in OCS-dependent, severe asthma with comorbid chronic rhinosinusitis with and without nasal polyps
Authors
Rabe KF; Castro M; Nair P; Rice MS; Rowe P; Deniz Y; Staudinger H; Graham NMH; Amin N; Teper A
Volume
74
Pagination
pp. 35-35
Publisher
WILEY
Publication Date
August 1, 2019
Name of conference
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)
Conference place
Lisbon, PORTUGAL
Conference start date
June 1, 2019
Conference end date
June 5, 2019
Conference proceedings
ALLERGY
ISSN
0105-4538